Related Experiment Video

Updated: Sep 26, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K

Long-Term Clinical Consequences of Patients Hospitalized for COVID-19 Infection

Sevgi Özcan1, Orhan İnce1, Ahmet Güner2

  • 1Department of Cardiology, Bağcılar Training and Research Hospital, İstanbul, Turkey.

Anatolian Journal of Cardiology
|April 18, 2022
PubMed

Insights

Persistent symptoms are common following Coronavirus Disease 2019 (COVID-19) hospitalization. Healthcare providers should be aware of these mid- to long-term consequences for improved patient aftercare.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, frequently leads to multi-organ injury.
  • Data on mid- to long-term consequences of COVID-19 post-hospitalization are limited.
  • This study addresses the need for understanding long-term COVID-19 outcomes.

Purpose of the Study:

  • To describe the mid- to long-term consequences of COVID-19 in hospitalized patients after discharge.
  • To identify predictors of persistent symptoms.

Main Methods:

  • A single-center, prospective study enrolled 406 discharged COVID-19 patients.
  • Follow-up included face-to-face interviews and questionnaires at 3 and 6 months.
  • Patients were classified by World Health Organization (WHO) severity grading (WHO-3, WHO-4, WHO-5,6).

Main Results:

  • Higher WHO severity groups showed significantly longer hospital stays.
  • The WHO-5,6 group had significantly longer ICU stays.
  • Chest pain was the most frequent symptom (39%), decreasing over follow-up.
  • Age, comorbidities, inflammatory markers, and treatment influenced cardiovascular symptom persistence.

Conclusions:

  • Persistent symptoms are common in hospitalized COVID-19 survivors.
  • Healthcare professionals need heightened awareness for COVID-19 aftercare.
  • Understanding predictors can guide post-discharge management.
Abstract

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.6K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
478
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
359
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
642
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
767
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
466